Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flex Vascular (formerly VentureMed Group, Inc.) is a privately held medical device company specializing in innovative endovascular solutions for vessel preparation and access management. The company's flagship product, the FLEX Vessel Prep System, is an FDA 510(k)-cleared and CE Mark-approved device designed to optimize vessel compliance prior to standard angioplasty. Utilizing proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology, the system creates long, precise micro-incisions to facilitate luminal gain and enhance drug uptake in patients with peripheral arterial disease (PAD) and arteriovenous (AV) fistulas or grafts. Flex Vascular is headquartered in Plymouth, Minnesota, and is backed by prominent life science investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FLEX Vascular.